Katherine Price
Contributor at The Caterer
Journalist at Freelance
Freelance journalist ✍️ Welsh 🏴 Switzerland📍🇨🇭 Bylines in @hosp_investor @PJOnline_News @HHE_Digital also @katherineprice.bsky.social
Articles
-
1 week ago |
pharmaceutical-journal.com | Katherine Price
The UK’s first safer drug consumption facility (SDCF) in Glasgow has been accessed 2,691 times during the four months it has been open, according to data published by the Glasgow City Health and Social Partnership. According to service data recorded by the SDCF, between January and April 2025, use of the service increased over the first three months — from 336 times in January to 864 times in March 2025 — before dropping slightly to 847 times in April 2025.
-
1 week ago |
pharmaceutical-journal.com | Katherine Price
The NHS Race and Health Observatory and the National Institute for Health and Care Excellence (NICE) have agreed five priority areas for de-biasing clinical guidance.
-
2 weeks ago |
pharmaceutical-journal.com | Katherine Price
Changes to hub-and-spoke dispensing regulations are expected to be permitted from October 2025, government draft legislation has revealed. The government has laid draft amendments to the Human Medicines Regulations 2012 (HMR) in parliament as the next step towards introducing hub-and-spoke dispensing between different legal entities, which the draft legislation said will come into force on 1 October 2025.
-
2 weeks ago |
pharmaceutical-journal.com | Katherine Price
Monoclonal antibody nirsevimab “provides strong real-world protection” against severe respiratory syncytial virus (RSV) in infants, a meta-analysis has found. The study, published on 1 May 2025 in The Lancet Child and Adolescent Health journal, analysed 27 studies conducted during the 2023/2024 RSV season across five countries: France, Italy, Luxembourg, Spain and the United States.
-
3 weeks ago |
pharmaceutical-journal.com | Katherine Price
Varenicline, a smoking cessation drug, could help young people quit vaping, study results have suggested. The study, published in JAMA on 23 April 2025, found that, among adolescents and young adults, varenicline was well tolerated and promoted vaping cessation when compared with a placebo among young people with moderate-to-severe addiction to vaped nicotine.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 2K
- Tweets
- 9K
- DMs Open
- Yes
RT @mjauk: English pharmacies twice as likely to give antibiotics for sore throat than Welsh pharmacies @katherineprice reports for @PJOnl…
I can't say I was a particularly natural cross country skier based on my first attempt 😅 however after a rough 20 minutes and a steep learning curve, we got there in the end https://t.co/rzzaCx3fBC
RT @freelancingfor: Don't forget to fill in our UK freelance journalism survey! We are so close to getting enough responses so we can relea…